Differential high density lipoprotein proteomic profile in heterozygous familial hypercholesterolemia

被引：0
|
作者：
Cubedo, J. [1 ]
Padro, T.
Alonso, R. [2 ]
Mata, P. [2 ]
Badimon, L. [1 ]
机构：
[1] UAB, Hosp St Pau, IIB St Pau, Barcelona Cardiovasc Res Ctr,CSIC ICCC,CiberOBN, Barcelona, Spain
[2] Fdn Jimenez Diaz, E-28040 Madrid, Spain
来源：
CARDIOVASCULAR RESEARCH | 2012年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S121 / S122
页数：2
相关论文
共 50 条
  • [21] A rare low-density lipoprotein receptor (LDLR) gene mutation associated with heterozygous familial hypercholesterolemia
    Ortiz Espejo, M.
    Batanero Maguregui, R.
    Montalban Carrasco, C.
    Piedra Leon, M.
    Garcia Sardina, R.
    Esparza Del Valle, C.
    Moyano Martinez, A.
    Diez Espiga, S.
    Iturralde Ros, M.
    CLINICA CHIMICA ACTA, 2019, 493 : S205 - S206
  • [22] Effect of simvastatin treatment on the electronegative low-density lipoprotein present in patients with heterozygous familial hypercholesterolemia
    Sánchez-Quesada, JL
    Otal-Entraigas, C
    Franco, M
    Jorba, O
    González-Sastre, F
    Blanco-Vaca, F
    Ordóñez-Llanos, J
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (06): : 655 - 659
  • [23] Atorvastatin in low-density lipoprotein apheresis-treated patients with homozygous and heterozygous familial hypercholesterolemia
    Goldammer, A
    Wiltschnig, S
    Heinz, G
    Jansen, M
    Stulnig, T
    Hörl, WH
    Derfler, K
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (08): : 976 - 980
  • [24] COMBINED TREATMENT WITH SIMVASTATIN AND ACIPIMOX IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA WITH ELEVATED LIPOPROTEIN(A)
    MULS, E
    BEX, M
    COBBAERT, C
    VANSANT, G
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 1994, 4 (02) : 78 - 82
  • [25] Lipoprotein(a) as a risk factor for calcific aortic valvulopathy in heterozygous familial hypercholesterolemia
    Vuorio, Alpo
    Watts, Gerald F.
    Kovanen, Petri T.
    ATHEROSCLEROSIS, 2019, 281 : 25 - 30
  • [26] Lipoprotein(a) is an independent risk factor for cardiovascular disease in heterozygous familial hypercholesterolemia
    Holmes, DT
    Schick, BA
    Humphries, KH
    Frohlich, J
    CLINICAL CHEMISTRY, 2005, 51 (11) : 2067 - 2073
  • [27] Macrophage lipoprotein lipase expression is increased in patients with heterozygous familial hypercholesterolemia
    Beauchamp, MC
    Letendre, É
    Renier, G
    JOURNAL OF LIPID RESEARCH, 2002, 43 (02) : 215 - 222
  • [28] ABNORMALITIES IN SERUM HIGH-DENSITY LIPOPROTEIN LEVELS AND DISTRIBUTION IN FAMILIAL HYPERCHOLESTEROLEMIA
    GOLDBERG, RB
    FLESS, GM
    SCANU, AM
    GETZ, GS
    SEFTEL, HC
    MENDELSSOHN, D
    RUBENSTEIN, AH
    CLINICAL RESEARCH, 1980, 28 (02): : A556 - A556
  • [29] THE EFFECT OF SIMVASTATIN TREATMENT ON THE LOW-DENSITY-LIPOPROTEIN SUBFRACTION PROFILE AND COMPOSITION IN FAMILIAL HYPERCHOLESTEROLEMIA
    DEGRAAF, J
    DEMACKER, PNM
    STALENHOEF, AFH
    NETHERLANDS JOURNAL OF MEDICINE, 1993, 43 (5-6): : 254 - 261
  • [30] NORMALIZATION OF LOW-DENSITY LIPOPROTEIN LEVELS AND DISAPPEARANCE OF XANTHOMAS DURING PREGNANCY IN A WOMAN WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    MABUCHI, H
    SAKAI, Y
    WATANABE, A
    HABA, T
    KOIZUMI, J
    TAKEDA, R
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1985, 34 (04): : 309 - 315
12345